These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2909993

  • 1. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
    Colucci WS.
    Am J Cardiol; 1989 Jan 03; 63(2):17A-22A. PubMed ID: 2909993
    [Abstract] [Full Text] [Related]

  • 2. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Marsh JD, Gauthier DF.
    J Clin Invest; 1988 Apr 03; 81(4):1103-10. PubMed ID: 2832444
    [Abstract] [Full Text] [Related]

  • 3. Myocardial and vascular actions of milrinone.
    Colucci WS.
    Eur Heart J; 1989 Aug 03; 10 Suppl C():32-8. PubMed ID: 2680495
    [Abstract] [Full Text] [Related]

  • 4. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar 03; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 5. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS.
    Circulation; 1986 Jan 03; 73(1):130-7. PubMed ID: 3940664
    [Abstract] [Full Text] [Related]

  • 6. Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure.
    Arnold JM, Ludmer PL, Wright RF, Ganz P, Braunwald E, Colucci WS.
    J Am Coll Cardiol; 1986 Aug 03; 8(2):413-8. PubMed ID: 3734263
    [Abstract] [Full Text] [Related]

  • 7. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb 03; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 03; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 9. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB.
    J Cardiovasc Pharmacol; 1987 Nov 03; 10(5):509-16. PubMed ID: 2447398
    [Abstract] [Full Text] [Related]

  • 10. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
    Grose R, Strain J, Greenberg M, LeJemtel TH.
    J Am Coll Cardiol; 1986 May 03; 7(5):1107-13. PubMed ID: 3958369
    [Abstract] [Full Text] [Related]

  • 11. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A, Herrmann G, Gerdesmeyer L, Simon R.
    Z Kardiol; 1992 May 03; 81(5):266-71. PubMed ID: 1621407
    [Abstract] [Full Text] [Related]

  • 12. Modulation of venous tone in heart failure.
    Muir AL, Nolan J.
    Am Heart J; 1991 Jun 03; 121(6 Pt 2):1948-50. PubMed ID: 2035425
    [Abstract] [Full Text] [Related]

  • 13. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
    Mehra MR, Ventura HO, Kapoor C, Stapleton DD, Zimmerman D, Smart FW.
    Am J Cardiol; 1997 Jul 01; 80(1):61-4. PubMed ID: 9205021
    [Abstract] [Full Text] [Related]

  • 14. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
    Gosgnach M, Gérard JL, Berdeaux A, Giudicelli JF.
    Fundam Clin Pharmacol; 1991 Jul 01; 5(8):709-18. PubMed ID: 1783360
    [Abstract] [Full Text] [Related]

  • 15. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
    Colucci WS, Leatherman GF, Ludmer PL, Gauthier DF.
    Circ Res; 1987 Oct 01; 61(4 Pt 2):I82-6. PubMed ID: 3652407
    [Abstract] [Full Text] [Related]

  • 16. In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure.
    Colucci WS.
    Circulation; 1990 Aug 01; 82(2 Suppl):I44-51. PubMed ID: 2164896
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of milrinone.
    Colucci WS.
    Am Heart J; 1991 Jun 01; 121(6 Pt 2):1945-7. PubMed ID: 2035424
    [Abstract] [Full Text] [Related]

  • 18. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
    Cody RJ, Müller FB, Kubo SH, Rutman H, Leonard D.
    Circulation; 1986 Jan 01; 73(1):124-9. PubMed ID: 3940663
    [Abstract] [Full Text] [Related]

  • 19. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct 01; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
    Mager G, Klocke RK, Volkmann A, Kux A, Höpp HW, Hilger HH.
    Z Kardiol; 1991 Feb 01; 80(2):149-57. PubMed ID: 2058247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.